Simont Braun is reputed for its depth of expertise in data protection, IP, commercial and corporate mandates, receiving praise for the 'high level of personal attention' it offers to its life sciences clients. Its esteemed roster includes corporations that are active in the pharmaceuticals, biotechnology, veterinary medicine and digital health sectors. The team is regularly instructed on complex cross-border patent litigation, regulatory strategy and market access. Co-head Eric De Gryse brings extensive experience in IP litigation, while co-head Alexis Ceuterick specialises in employment and social security matters.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- ‘We are very satisfied with the law firm Simont Braun because they communicate clearly and are very responsive, which includes returning our emails and/or phone calls quickly. We have a direct line to our lead attorney, who handles our case from beginning to end. They are focused on the unique circumstances and aims of each of our cases and provide a high level of personal attention.’
- ‘Our main contact is Tom Swinnen. We highly appreciate his responsiveness, practical guidance and full-service counselling. In comparison to outside counsel we use in other geographies, he is always available, focused on delivering excellent practical support and reaching mutually satisfactory solutions.’
Key clients
- Doctor Anytime
- Groupe Well
- IP Improved Products by Breeding UG
- Eurofins
- GE HealthCare Technologies Inc
- EG
- Yves Rocher
- Formycon – Klinge Biopharma
Work highlights
Advising Formycon in the Belgian part of cross-border patent litigation in relation to biosimilar medicinal products.
Represented Doctor Anytime, a start-up that developed into a major online platform for medical appointments and healthcare services. Privacy issues are being litigated before the Brussels Court of Appeal against the Belgian privacy authority following a complaint from non-participating doctors acting on behalf of a competing service. The importance of these services (now authorised, but regulated) has increased heavily since the pandemic.
Assisted GE HealthCare Technologies Inc., a leading global medical technology, pharmaceutical diagnostics, and digital innovator with a market cap of c.$40bn, with the acquisition of the American-based MIM Software Inc.
Practice head
Eric De Gryse; Alexis Ceuterick
Other key lawyers
Emmanuel Cornu; Tom Swinnen